Ritivixibat

Overview

Ritivixibat is an apical sodium-dependent bile acid transporter ( ASBT/IBAT ) inhibitor. Ritivixibat blocks ASBT/IBAT function, thereby reducing bile acid reabsorption, regulating bile acid homeostasis and alleviating liver injury. Ritivixibat protects cholangiocytes from damage caused by cytotoxic bile acids. Ritivixibat is applicable to research related to primary sclerosing cholangitis.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Apical Sodium-Dependent Bile Acid Transporter

Product Information

• Catalog No.: HY-148795
• CAS No.: 2460667-52-9
• Molecular Formula: C26H36N2O5S2
• Molecular Weight: 520.70
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source